SPONSOR PROFILE

Leading with purpose. Every day.

“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”

Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President

Information

SLEP, the Latin American Society of Pediatric Endocrinology was founded in 1986 under the leadership of César Bergadá. The main objective of the society is to integrate pediatric endocrinologists, biochemists, pediatricians, endocrinologists or professionals from similar areas for the development of pediatric endocrinology in the broadest sense in Latin America.

Contact

For registration related queries please contact:
slep-registration@wearemci.com

For general congress inquiries: slep@wearemci.com

Español English Portugues